CAS 1334493-07-0

BP-1-102

CAS: 1334493-07-0

Fórmula: C₂₉H₂₇F₅N₂O₆S

Pureza: %

Forma y color: Solid

Peso molecular: 626.5915

Ref: IN-DA01A2GD

BP-1-102

CAS: 1334493-07-0

BP-1-102

Pureza: ≥98%

Peso molecular: 626.59g/mol

Ref: 54-BUP02850

BP-1-102

CAS: 1334493-07-0

BP-1-102 is an orally active, effective and specific STAT3 inhibitor.

Fórmula: C₂₉H₂₇F₅N₂O₆S

Pureza: 99.25% - 99.44%

Forma y color: Solid

Peso molecular: 626.59

Ref: TM-T3708

BP 1-102

CAS: 1334493-07-0

BP 1-102 is a monoclonal antibody that targets PD-L1. It binds to PD-L1, blocking the interaction between PD-L1 and its ligands such as PD-1, B7-H3, and B7-H4. This prevents the inhibitory signals from reaching T cells and other immune cells, leading to an increase in T cell proliferation and activation. BP 1-102 has been shown to have minimal toxicity in animal studies. The drug was well tolerated with no significant changes in body weight or organ weight measurements. BP 1-102 also showed efficacy in preclinical models of cancer by inhibiting tumor growth and increasing cancer cell death (apoptosis). In addition, BP 1-102 has been shown to have an anti-inflammatory effect on IL17a production by T cells.

Fórmula: C₂₉H₂₇F₅N₂O₆S

Pureza: Min. 95%

Peso molecular: 626.59 g/mol

Ref: 3D-JDC49307